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Both endocrine and exocrine pancreatic cells arise from pancreatic-duodenal homeobox 1 (pdx1)-positive progenitors.
The molecular mechanisms controlling cell fate determination and subsequent proliferation, however, are poorly
understood. Unlike endocrine cells, less is known about exocrine cell specification. We report here the identification
and characterization of a novel exocrine cell determinant gene, exocrine differentiation and proliferation factor (exdpf),
which is highly expressed in the exocrine cell progenitors and differentiated cells of the developing pancreas in
zebrafish. Knockdown of exdpf by antisense morpholino caused loss or significant reduction of exocrine cells due to
lineage-specific cell cycle arrest but not apoptosis, whereas the endocrine cell mass appeared normal. Real-time PCR
results demonstrated that the cell cycle arrest is mediated by up-regulation of cell cycle inhibitor genes p21
Cip, p27
Kip,
and cyclin G1 in the exdpf morphants. Conversely, overexpression of exdpf resulted in an overgrowth of the exocrine
pancreas and a severe reduction of the endocrine cell mass, suggesting an inhibitory role for exdpf in endocrine cell
progenitors. We show that exdpf is a direct target gene of pancreas-specific transcription factor 1a (Ptf1a), a
transcription factor critical for exocrine formation. Three consensus Ptf1a binding sites have been identified in the
exdpf promoter region. Luciferase assay demonstrated that Ptf1a promotes transcription of the exdpf promoter.
Furthermore, exdpf expression in the exocrine pancreas was lost in ptf1a morphants, and overexpression of exdpf
successfully rescued exocrine formation in ptf1a-deficient embryos. Genetic evidence places expdf downstream of
retinoic acid (RA), an instructive signal for pancreas development. Knocking down exdpf by morpholino abolished
ectopic carboxypeptidase A (cpa) expression induced by RA. On the other hand, exdpf mRNA injection rescued
endogenous cpa expression in embryos treated with diethylaminobenzaldehyde, an inhibitor of RA signaling.
Moreover, exogenous RA treatment induced anterior ectopic expression of exdpf and trypsin in a similar pattern. Our
study provides a new understanding of the molecular mechanisms controlling exocrine cell specification and
proliferation by a novel gene, exdpf. Highly conserved in mammals, the expression level of exdpf appears elevated in
several human tumors, suggesting a possible role in tumor pathogenesis.
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Introduction
The pancreas is a mixed organ with endocrine and
exocrine compartments. The endocrine portion contains
four distinct hormone-producing cell types organized into
islets of Langerhans. Autoimmune-mediated destruction of
endocrine b cells causes type 1 diabetes [1,2]. b cell number
also gradually declines in type 2 diabetes [2]. The exocrine
portion includes acinar cells, which produce digestive
enzymes, and duct cells, which form an elaborate duct system
that transports these enzymes into the gut. The majority of
malignant pancreatic cancers derive from the exocrine
portion [3]. Development of all major pancreatic cell types,
including endocrine, exocrine, and duct cells, requires the
function of the pancreatic-duodenal homeobox 1 (Pdx1, also known
as Ipf-1) gene [4,5]. The molecular mechanisms determining
early cell fate and the subsequent proliferation of endocrine
and exocrine cells are not fully understood. Identiﬁcation
and characterization of novel lineage-speciﬁc regulators of
exocrine pancreas cell proliferation could shed light on the
pathogenesis of pancreatic cancers.
Morphogenesis of the pancreas in zebraﬁsh (Danio rerio)
shares some similarities to that in the mouse. In mice, the
pancreas develops from one dorsal and one ventral bud that
arise from the posterior foregut [6–8] sequentially. The
recognizable dorsal pancreatic bud forms from the prepat-
terned endoderm at around 22–25 somites (embryonic day
Academic Editor: Derek Stemple, Wellcome Trust Sanger Institute, United
Kingdom
Received June 18, 2008; Accepted October 14, 2008; Published November 25,
2008
Copyright:  2008 Jiang et al. This is an open-access article distributed under the
terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author
and source are credited.
Abbreviations: atRA, all-trans retinoic acid; Cpa, carboxypeptidase A; DEAB,
diethylaminobenzaldehyde; dpf, day(s) postfertilization; E[number], embryonic day
[number]; Exdpf, exocrine differentiation and proliferation factor; GFP, green
fluorescent protein; hpf, hour(s) postfertilization; Pdx1, pancreatic-duodenal
homeobox 1; Ptf1a, pancreatic transcription factor 1, alpha subunit; RA, retinoic
acid; RT-PCR, reverse transcriptase PCR; SD, standard deviation
* To whom correspondence should be addressed. E-mail: bzhang@pku.edu.cn (BZ);
shuolin@ucla.edu (SL)
[ These authors contributed equally to this work.
PLoS Biology | www.plosbiology.org November 2008 | Volume 6 | Issue 11 | e293 2450
PLoS BIOLOGY9.5 [E9.5]) and the ventral bud arises slightly later at around
30 somites (E10.25 to E10.5). Then the dorsal and ventral buds
fuse as a result of gut rotation at E12.5 [9]. Different
endocrine cell types are speciﬁed at different stages. The a
and b cells mature at E9.5 since glucagon and preproinsulin can
be detected by immunohistochemistry [10], whereas soma-
tostatin can be detected only at E13.5 [11,12]. Initially, it had
been thought that the zebraﬁsh pancreas develops from a
single pancreatic anlage that appears at around 15 h
postfertilization (hpf) [13–15]. This posterodorsal pancreatic
anlage gives rise only to endocrine cells. Using a gut:GFP
transgenic line, however, Field et al. observed a second anlage
(ventral anlagen) that arose from the foregut at 34 hpf [16]
when exocrine cells begin differentiation. In addition to
exocrine cells, this anteroventral anlage also contributes to
endocrine cells that are scattered outside of the main islet
[16].
The dynamic process of pancreatic development is
controlled by extrinsic signals from the adjacent tissues and
intrinsic transcription factors. Multiple signals including
ﬁbroblast growth factor [17,18], bone morphogenetic protein
[19], Notch [17,20–22], and sonic hedgehog [23] play critical
roles for proper pancreas formation. A conserved role of
retinoic acid (RA) has been reported in many organisms,
including zebraﬁsh [24,25], Xenopus [26], and mouse [27,28].
There are conﬂicting data, however, on the relative effects of
RA on endocrine and exocrine pancreas differentiation. In
Xenopus, RA treatment promotes endocrine at the expense of
exocrine differentiation in the dorsal bud by inhibiting Notch
signaling activity [26]. In zebraﬁsh, RA treatment results in
anterior expansion of endocrine and exocrine cells [25]. It
appears that RA acts directly in the endoderm to induce
endocrine pancreatic precursors [29]. In mouse embryonic
pancreas cultures, all-trans retinoic acid (atRA) inhibits
branching morphogenesis and exocrine cell differentiation
but accelerates endocrine differentiation, possibly due to
increased level of Pdx1 in the endocrine clusters [30]. The
differential effects may be explained by the distribution of
the RAR and RXR receptors in the developing mouse
pancreas [31].
A network of intrinsic transcription factors that act in a
cascade fashion to initiate and maintain cell-speciﬁc gene
expression patterns determines the ultimate lineage-speciﬁc
cell fate. One of the earliest transcription factors functioning
in the developing pancreatic epithelium is PDX1, which plays
an essential role during the early phase of pancreas develop-
ment. Mice with a targeted mutation in the Pdx1 gene
exhibited no development of pancreatic tissue [4]. The
agenesis of the pancreas is caused by an early arrest right
after initial bud formation [4,5]. Furthermore, multiple roles
of Pdx1 in cell lineage determination during pancreas
formation has been revealed by lineage tracing using a
modiﬁed version of Cre/lox technology [32]. Cells labeled
between E9.5 and E11.5 give rise to all three pancreatic cell
lineages including islet, exocrine acini, and ducts. Conversely,
cells labeled at E8.5 and E.12.5 or thereafter give rise only to
endocrine and acinar cells [32]. These results suggest that
temporal regulation of Pdx1 expression is critical for cell fate
determination. In addition, several transcription factors have
been identiﬁed as endocrine speciﬁc determinants. Neuro-
genin 3 (Ngn3) is one of the most important endocrine
speciﬁc transcription factors [20,33]. In contrast to the
endocrine lineage, little is known about the mechanisms that
control the differentiation of exocrine and ductal lineages.
Initially, pancreatic transcription factor 1, alpha subunit
(Ptf1a) had been considered an exocrine speciﬁc transcrip-
tion factor since its expression becomes restricted to
exocrine cells by E13.5 in mice [34]. However, cell lineage
tracing experiments revealed that ptf1a-expressing cells give
rise to all pancreatic cell types [35].
Here, we provide several lines of evidence indicating that
exocrine differentiation and proliferation factor (exdpf), a novel gene
identiﬁed from zebraﬁsh but highly conserved in mouse and
human, is an exocrine cell determinant and required
regulator of cell proliferation. The protein encoded by exdpf
is a putative signaling molecule and is expressed highly in the
exocrine cells during pancreas formation in zebraﬁsh.
Knocking down exdpf by antisense morpholino caused
signiﬁcant reduction or loss of expression of exocrine
markers. In contrast, overexpression of exdpf resulted in the
overgrowth in size of the exocrine pancreas and remarkable
decrease of endocrine cells. This result suggests that
misexpression of exdpf in the endocrine precursors is able
to transform their fate. We further show that the reduction of
exocrine cells in exdpf morphants is due to lineage-speciﬁc
cell cycle arrest. Real-time PCR revealed that the expressions
of cell cycle inhibitor genes p21
Cip and p27
Kip are dramatically
increased in the exdpf morphants. To test the effect of RA on
exocrine cell differentiation, we performed an epistatic study
of exdpf and the RA pathway. The results show that exdpf acts
genetically downstream of RA. Exogenous RA treatment
induced anterior ectopic exocrine cells via exdpf induction.
Moreover, injection of exdpf mRNA partially restored exo-
crine cell differentiation at the endogenous area in embryos
treated with exogenous RA, whereas the expansion of
endocrine cells were reduced. Our data establish a critical
role of exdpf in exocrine cell fate determination and
proliferation. Being a vertebrate-speciﬁc gene, the exdpf
orthologs are highly conserved from ﬁsh to human. A search
of National Center for Biotechnology Information (NCBI)
database revealed that the human exdpf ortholog expression is
up-regulated in several human cancers including hepatic,
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Author Summary
The pancreas is a vital organ comprising endocrine and exocrine
components. Both endocrine and exocrine cells derive from a
common pool of progenitors present in the gut endoderm during
embryogenesis. The molecular mechanisms regulating cell fate
decisions and lineage-specific proliferation are not fully understood.
In this work, we report the characterization of a novel gene, exocrine
differentiation and proliferation factor (exdpf), as a regulator for
exocrine cell fate and differentiation/proliferation. We show that it is
a direct target of the transcription factor pancreas-specific tran-
scription factor 1a (Ptf1a), which is expressed in progenitors that
give rise to all pancreatic cell types. We find that a deficiency of
exdpf results in a severe reduction of exocrine size due to defects in
cell proliferation. Consistent with this finding, overexpression of
exdpf leads to an increase of exocrine size and a decrease of
endocrine size, suggesting a possible change in fate of the
endocrine progenitors. The human ortholog of exdpf is highly
conserved and its expression level appears elevated in several
cancers, including hepatic and pancreatic cancers, implying a
possible role in pathogenesis of these malignancies.pancreatic, and renal cancers, suggesting that overexpression
or mutation in the exdpf gene might be involved in the
pathogenesis of cancers.
Results
Vertebrate Orthologs of the exdpf Gene Are Highly
Conserved
In our effort to identify pancreas speciﬁc genes, we isolated
the exdpf gene (GeneID: 338304 [http://www.ncbi.nlm.nih.gov/
sites/entrez]) from a RNA whole-mount in situ hybridization
screen in zebraﬁsh (our unpublished data). A BLAST search
of the zebraﬁsh genome revealed a homolog of exdpf named
endocrine differentiation and proliferation factor (endpf, not
described here). The deduced peptide encoded by the exdpf
gene contains 117 amino acids. Multiple sequence alignments
using ClustalW showed that the Exdpf protein is speciﬁc to
vertebrates and highly conserved across the vertebrates
including zebraﬁsh, mouse, and human (Figure S1A). The
human and mouse orthologs are known as uncharacterized
novel open reading frames (c20orf149, Gene ID: 79144 and
AK154758). Overall, the deduced protein is about 42%
identical across different species. The N terminus is highly
conserved whereas the C terminus is more diversiﬁed, which
suggests that subtle functional differences might lie in the C
terminus. In addition, synteny analysis showed that a cluster
of homologous genes is also conserved between zebraﬁsh and
human at the exdpf loci (Figure S1B).
The exdpf Gene Is Highly Expressed in the Exocrine Cells
during Pancreas Formation in Zebrafish
We studied the temporal and spatial expression of exdpf by
reverse transcriptase PCR (RT-PCR) and whole-mount in situ
hybridization. RT-PCR results (Figure S2) indicated that the
exdpf transcript is maternally deposited since it was detected
at the one-cell stage. The amount of exdpf transcript reduced
following the one-cell stage, and the lowest level was detected
at the shield stage. Then exdpf expression gradually increased
from shield stage and a strong level was detected between 1 d
postfertilization (dpf) and 2 dpf when the exocrine pancreas
starts to develop; the highest level of expression was detected
between 2 dpf and 5 dpf, the longest time point of this study.
This result suggests that zygotic expression of the exdpf gene
starts at around the shield stage.
We then performed RNA whole-mount in situ hybrid-
ization using an exdpf probe to obtain detailed expression
analysis of exdpf in the developing pancreas. Double in situ
hybridization was performed using either a preproinsulin
probe to locate the endocrine b cells or a trypsin probe to
mark the exocrine cells in combination with the exdpf probe.
Exdpf transcripts were ﬁrst detected in the developing somites
at 8.5 hpf (Figure 1A). From the three-somite to 21-somite
stage, exdpf was expressed in somites, adaxial cell, slow muscle
ﬁber, and epiphysis (Figure 1B–1E). Interestingly, exdpf started
to express in the pancreatic area at 33 hpf (Figure 1F), just
before exocrine speciﬁcation begins. Later in development,
the strongest domain of exdpf expression appeared in the
pancreas. Cells expressing exdpf (blue staining in Figure 1F)
were located about one somite anterior to the cluster of
preproinsulin-positive cells (red staining in Figure 1F). By 36
hpf, exdpf-expressing cells started to contact the preproinsulin-
positive cells (Figure 1G) as a result of gut rotation. By 2 dpf,
exdpf-expressing cells embraced the cluster of preproinsulin-
positive cells (unpublished data). These exdpf-expressing cells
continue to grow posteriorly to form a typical pancreas-like
shape at 3 dpf (Figure 1H–1J). From 33 hpf to 3 dpf, there was
no overlap between exdpf-expressing cells and preproinsulin-
positive cells, indicating that exdpf expression is excluded
from endocrine cells. Conversely, exdpf transcripts completely
overlap with trypsin expression at 3 dpf (Figure 1J). To
conﬁrm the exocrine-speciﬁc expression of exdpf at 4 dpf, we
performed a double in situ hybridization using an exdpf probe
and a probe against carboxypeptidase A (cpa), another exocrine
marker. As expected, exdpf expression completely overlaps
with cpa expression at 4 dpf (unpublished data). Together,
these data suggest that exdpf is expressed exclusively in the
exocrine cells during pancreas development.
Reduced exdpf Impairs Exocrine Cell Differentiation and
Growth
Based on the expression pattern of exdpf, we postulated that
it is required for exocrine pancreas development. To test this
hypothesis, we knocked down exdpf by injection of antisense
morpholino oligonucleotides (MO1
exdpf and MO2
exdpf) de-
signed to interfere with its translation. We tested both
morpholinos to assure that the phenotypes observed are due
to the speciﬁc knockdown of exdpf. A morpholino standard
control oligonucleotide from Gene Tools was used to inject
the control embryos. No speciﬁc phenotypes were observed
in these control embryos. Double in situ hybridization using a
trypsin probe and a preproinsulin probe was performed to
assess the effect on exocrine and endocrine development
simultaneously. In the control embryos, b cells formed a
cluster (islet) that was surrounded by exocrine cells at the
anterior area of the pancreas (head) at 3 dpf (Figure 2A). Both
the b cell mass and exocrine mass increased at 5 dpf in the
control embryos (Figure 2B). In addition, exocrine cells
expanded posteriorly to form a typical pancreas like shape
(Figure 2A and 2B). The majority of embryos injected with 2
ng of exdpf morpholino (MO1
exdpf) exhibited no trypsin
expression at 3 dpf (86%, n ¼ 50) or 5 dpf. However, there
were a few embryos (14%, n¼50) with reduced exdpf function
that showed severe reduction of trypsin expression at 3 dpf
and the remaining exocrine cells were restricted to the
anterior pancreatic area engulﬁng the endocrine cells (Figure
2C). Furthermore, the exocrine cells failed to grow and
expand posteriorly by 5 dpf (Figure 2D). In contrast, the
endocrine cells looked largely normal in exdpf morphants
(Figure 2C and 2D). Only a small fraction of exdpf morphants
(10%, n ¼ 50) showed scattered preproinsulin cells at 5 dpf
(unpublished data). These results indicate that exdpf is
required speciﬁcally for exocrine cell differentiation and
growth. Over 90% of MO2
exdpf morphants exhibited similar
phenotypes (Figure S3). To investigate the function of exdpf in
the differentiated exocrine cells, we used MO1
exdpf for the rest
of this study because it gave milder phenotypes.
We then studied early exocrine differentiation using a ptf1a
probe. The protein encoded by ptf1a is a basic helix-loop-
helix (bHLH) transcription factor that plays a critical role in
exocrine pancreas development. A null mutation of Ptf1a in
mouse leads to complete agenesis of exocrine pancreas and
spatially disorganized endocrine pancreas [34,35]. In zebra-
ﬁsh, ptf1a loss of function by antisense morpholino injection
suppresses exocrine markers without affecting endocrine
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Exdpf Controls Exocrine Pancreas Formationmarkers and the organization of the main islet [36,37]. Since
ptf1a can serve as an early marker of exocrine development
[36], we analyzed ptf1a expression in exdpf morphants at 2 dpf
and 3 dpf by whole-mount in situ hybridization. In the
control embryos, ptf1a-expressing cells formed a loose cluster
at 2 dpf (Figure 2E) and the expression expanded toward the
posterior with exclusion from the endocrine cells at 3 dpf
(Figure 2F). Expression of ptf1a was missing in the vast
majority of exdpf morphant embryos (85%, n ¼ 50). In a small
fraction of exdpf morphants (15%, n¼50), initial expression of
ptf1a appeared normal at 2 dpf (Figure 2G). But the
expression of ptf1a failed to expand towards the posterior
by 3 dpf (Figure 2H) and remained in the same area as in 2
dpf. This result conﬁrms that exdpf is critical for exocrine cell
speciﬁcation and expansion.
The exdpf gene is expressed in the developing somites as
well as the exocrine pancreas (Figure 1). To clarify whether
the exocrine pancreas defect is due to pleiotropic abnormal-
ities, we used a recently obtained transgenic ﬁsh MP760GFP
(our unpublished data) that expresses green ﬂuorescent
protein (GFP) in the developing liver, gut, and pancreas. In
this transgenic line, pancreatic expression of GFP is restricted
in the exocrine portion. A minimal amount of exdpf
morpholino was used to achieve the least amount of defects
in overall body morphology. At 24 hpf, strong expression of
GFP was observed in the presumed pancreatic area in both
control embryos and exdpf mRNA injected embryos (Figure
S5A and S5B, arrows). By 2 dpf, pancreatic GFP expression
became more obvious in the control and exdpf mRNA-injected
embryos (Figure S5A and S5B, arrowheads). In contrast, only
residual or no pancreatic GFP expression was observed in
exdpf morphants (Figure S5C). However, gut GFP expression
in exdpf morphants (Figure S5C) remained comparable to that
in the control embryos (Figure S5A).
Exdpf is also expressed in the developing liver (Figure 1)
during embryogenesis. To assess whether it is required for
liver development, in situ hybridization was performed using
a ceruloplasmin (cp) probe. At 3 dpf, clear expression of cp was
detected in the livers of control embryos injected with
standard morpholino control (Figure S5D). No detectable
change of cp expression was observed in exdpf morphants
(Figure S5E–S5G). This might be due to the redundant
function of exdpf homolog endpf since it is also expressed in
the developing liver.
Figure 1. Spatiotemporal Expression of exdpf during Zebrafish Embryogenesis
(A–L) In situ hybridization using an exdpf probe or an exdpf probe in combination with an preproinsulin probe (F, G and I) or a trypsin probe (J). (A) 8.5
hpf, dorsal view with anterior on the top. (B) 3-somite, dorsal view with anterior to the left. (C-G) Lateral view with anterior to the left. (C) 6-somite. (D)
12-somite. (E) 21-somite. Note strong expression in muscle area. (F) 33 hpf. (G) 36 hpf. In (F and G): Black arrowhead: epiphysis. Blue: exdpf probe; Red:
preproinsulin probe. Inset: enlargement of pancreatic area. (H-J) Dorsal view with anterior to the left. (H) 3 dpf. Black arrow: pancreas. White arrow: liver.
(I) 3 dpf. Double in situ hybridization using an exdpf probe (purple) and an preproinsulin probe (red). Note exdpf positive cells encircle preproinsulin-
expressing cells; but exdpf is not expressed in those cells. (J) 3 dpf. Double in situ hybridization using an exdpf probe (blue) and a trypsin probe (red).
Note that exdpf and trypsin perfectly overlap. (K, L) 5 dpf. (K) Lateral view with anterior to the left. Black arrow: pancreas. (L) Dorsal view with anterior to
the left. Black arrow: pancreas. White arrow: liver. Black arrowhead: epiphysis. Scale bar for (I, J): 50 lm.
doi:10.1371/journal.pbio.0060293.g001
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We further studied the genetic interaction between ptf1a
and exdpf. In mild exdpf morphants (injected with 2 ng of
MO1
exdpf), ptf1a expression was initiated but restricted to the
anterior area in 72% of embryos (Figure 2G, n ¼ 90),
indicating that exocrine cell differentiation can start but
expansion fails. However, only 15% of embryos (n ¼ 50) still
exhibited ptf1a expression when injected with 4 ng of
MO1
exdpf, suggesting a role for exdpf in exocrine cell differ-
entiation. Knocking down ptf1a by morpholino injection
(Figure 3) resulted in agenesis of the exocrine pancreas
(Figure 3C); only about 5% of ptf1a morphants exhibited weak
cpa expression (n ¼ 189, Table 1). In the control embryos,
injection of exdpf mRNA led to a great expansion of the
exocrine pancreas (Figure 3B). Interestingly, injection of exdpf
mRNA into ptf1a morphants successfully restored expression
of exocrine marker cpa to about 70% of embryos (Figure 3D–
3F, n ¼ 168). About 35% of embryos exhibited nearly full
restoration of cpa expression in the ptf1a morphants when
exdpf mRNA was injected, whereas another 35% exhibited
partial restoration (Table 1). In a reciprocal experiment,
injection of ptf1a mRNA into exdpf morphants failed to rescue
expression of exocrine markers (unpublished data). Together,
these results place exdpf genetically downstream of ptf1a in
exocrine development.
To test whether ptf1a functions through exdpf in exocrine
speciﬁcation, we performed in situ hybridization analysis of
exdpf in ptf1a morphants (Figure 4). Indeed, exdpf expression in
the exocrine pancreas was abolished in such embryos, as
expected (Figure 4B). However, the epiphysis expression of
exdpf remained unchanged in the ptf1a morphants (Figure 4B,
inset), indicating that ptf1a speciﬁcally controls pancreatic
expression of exdpf. Ptf1 is an unusual heterotrimeric bHLH
transcription factor composed of Ptf1a/P48, a common class
A bHLH protein (such as HEB, E2–2, E12, or E47, also called
Figure 2. Exdpf Is Required for the Exocrine Pancreas Differentiation and
Expansion
(A–D) Double in situ hybridization using a trypsin probe (red) and a
preproinsulin probe (blue). (A and B) Wild type (WT) embryos. (C and D)
Embryos injected with exdpf morpholino. (A) A 3 dpf embryo. Note
exocrine pancreas already expanded. (B) A 5 dpf embryo. Note both
endocrine and exocrine mass increased. (C) An example of exdpf
morphants, 3 dpf. Note exocrine mass is restricted to the anterior area,
whereas endocrine portion appears normal. (D) An example of exdpf
morphant at 5 dpf. Note exocrine pancreas is still restricted to the
anterior area with limited increase in mass. All embryos are mounted in
dorsal view, anterior to the left. Scale bar: 100 lm.
(E–H) In situ hybridization using a Ptf1a probe. Dorsal view, anterior to
the left. (E and F) Wild type embryos at 2 dpf and 3 dpf, respectively. (G
and H) Examples of exdpf morphants at 2 dpf and 3 dpf, respectively.
Note Ptf1a expression is restricted to the anterior area at 2 dpf (G); the
expression is still limited in the anterior area and the mass does not
increase at 3 dpf (H). Scale bar: 50 lm.
doi:10.1371/journal.pbio.0060293.g002
Figure 3. Exdpf Restores Expression of the Exocrine Cell Marker in Ptf1a
Morphants
(A–C) In situ hybridization using a carboxypeptidase A (cpa) probe in 3
dpf embryos. (A) A control embryo injected with water. (B) An embryo
injected with 100 pg of exdpf mRNA. Note enhanced expression of cpa.
(C) An embryo injected with 2 ng of Ptf1a morpholino. No expression of
cpa was detected.
(D–F) Embryos injected with 100 pg of exdpf mRNA followed by 2 ng of
Ptf1a morpholino. (D) Almost full restoration of cpa expression. (E) No
detectable cpa expression in the presumed exocrine area (arrow). (F)
Partial restoration of cpa expression. All embryos are shown in lateral
view, anterior to the left. Scale bar: 50 lm.
(G) Percentage of embryos with cpa expression at 3 dpf. Y-axis represents
mean 6 SD.
doi:10.1371/journal.pbio.0060293.g003
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Exdpf Controls Exocrine Pancreas FormationE-proteins), and a third protein that can be either the
mammalian Suppressor of Hairless RBP-J or its paralog, RBP-
L [38,39]. Ptf1 binding sites are bipartite with an E-box
(CANNTG) and a TC-box (TTTCCC) spaced one or two
helical turns apart, center to center [39–41]. The hetero-
dimeric subcomplex of Ptf1a and the E-protein binds to the
E-box and RBP-J or RBP-L binds to the TC-box [39,41].
Binding of the Ptf1 complex to DNA requires both boxes, and
the spacing between these elements is critical for Ptf1 binding
[42]. Functional binding sites for the Ptf1 complex are
present in the 59 promoter regions of all of the acinar
digestive enzyme genes examined [40,41]. To determine
whether Ptf1a might indeed control the transcription of
exdpf, we searched the 5-kb 59 ﬂanking region and intronic
sequences of this gene for potential PTF1-binding sites
comprising an E-box and a TC-box spaced one or two helical
DNA turns apart. Three potential binding sites were detected.
Binding site 1 is about 3 kb upstream of the transcriptional
start site (Figure 4C) and binding site 2 is around 1 kb
upstream of the transcriptional start site (Figure 4C); binding
site 3 is about 500 bp downstream of the transcriptional start
site in the ﬁrst intron (Figure 4C).
A 3.6-kb exdpf promoter region containing the transcrip-
tional start and three potential PTF1-binding sites increased
the activity of the luciferase reporter plasmid 41-fold
compared to the promoterless pGL3-Basic in HEK 293 cell
lines tested by transfection (Figure 4D, seq1). While deletion
of binding site 1 reduced the activity to 29-fold, a 1.5 kb
promoter region that retained binding site 2 and binding site
3 still maintained an activity of 26-fold (Figure 4D, seq 2 and
seq 3). However, deletion of binding site 1 and binding site 3
reduced the activity to 8-fold (Figure 4D, seq4). Not
surprisingly, deletion of all three binding sites further
reduced the transcription of the reporter gene almost to a
basal level (Figure 4D, seq 5). These results provide strong
evidence that Ptf1a can promote the transcription of exdpf,
and Ptf1-binding site 1 and binding site 3 are especially
critical for the activation of the promoter. Taken together,
these data demonstrate that exdpf is a direct target gene of
Ptf1a.
Excess exdpf Causes Increases in Exocrine Pancreas Mass
To assess whether exdpf is sufﬁcient for exocrine speciﬁca-
tion, we carried out overexpression experiments by injecting
synthetic exdpf mRNA into embryos at the one-cell stage
(Figure 5). Elastase A:GFP transgenic ﬁsh were used to
facilitate the identiﬁcation of exocrine cells. In this ﬁsh,
GFP expression is controlled by the elastase A (elaA) regulatory
sequence which allows exocrine speciﬁc GFP expression in
larvae and adult [43]. At 3 dpf, the average exocrine cell
number in the control embryo is 197.8 6 8.2 (Figure 5C;
Table 1. Quantitative Data of cpa Expression in Ptf1a Morphants
Group Full or Near Full cpa Expression Partial cpa Expression No cpa Expression Total Embryo Number
Ptf1a MO 0 (0%) 10 (5.29%) 179 (94.7%) 189
Ptf1a MO þ exdpf mRNA 58 (34.5%) 60 (35.7%) 50 (29.8%) 168
exdpf mRNA 114 (93.4%) 3 (2.5%) 5 (4.1%) 122
doi:10.1371/journal.pbio.0060293.t001
Figure 4. Exdpf Expression Is Regulated by Ptf1a
(A and B) In situ hybridization using an exdpf probe in 3 dpf embryos. (A)
An embryo injected with standard morpholino control. Inset: epiphysis
expression. (B) An embryo inject with Ptf1a morpholino. Inset: epiphysis
expression. Note that no exocrine expression of exdpf was detected. All
embryos are shown in lateral view, anterior to the left. Scale bar: 50 lm.
(C) Locations and sequences of the three potential PTF1 binding sites in
zebrafish exdpf gene and different exdpf promoter segments used in
luciferase assay. The E-box and TC-box are underlined and capital letters
indicate conserved nucleotides. The nucleotides that are not confirmed
to the conserved nucleotides are in red. Dots indicate the spaces
between the E-box and TC-box.
(D) Comparison of the activities of the segments containing different Ptf1
binding sites when transfected into 293 cells. These segments were
inserted just before the ORF of luciferase gene. Luciferase reporter
activity was adjusted for transfection efficiency and expressed relative to
the promoterless pGL3-Basic vector. Error bars represent standard
deviations.
doi:10.1371/journal.pbio.0060293.g004
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Exdpf Controls Exocrine Pancreas FormationFigure 5. Reduced exdpf Causes Defects of Exocrine Cell Proliferation
(A) BrdU labeling result in 33 hpf embryos. Green: MP760:GFP, Red: BrdU staining. Blue: DAPI staining. Dorsal view, anterior to the left. Enlargement
represents higher magnification of boxed area in each row. Arrows indicate non-proliferating cells; arrowheads indicate proliferating cells as evidenced
by overlapping of red and green colors.
(B) BrdU labeling result in 3 dpf embryos. Green: elastase A:GFP, Red: BrdU staining. Lateral view, anterior to the left. Scale bar: 50 lm. Arrows indicate
non-proliferating cells; arrowheads indicate proliferating cells as evidenced by overlapping of red and green colors.
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Exdpf Controls Exocrine Pancreas FormationTable 2, control, mean 6 standard deviation [SD], n ¼ 5).
Overexpression of exdpf caused a mild increase of exocrine
mass by about 28% (Figure 5C, Table 2, 253 6 4.2).
Conversely, knocking down exdpf by morpholino remarkably
reduced exocrine cell number to about 10% of control level
(21.6 6 3.4) at 3 dpf (Figure 5C, Table 2). At 5 dpf, exocrine
cell number was further increased by 42.8% in exdpf mRNA
injected embryos (Figure S6D, 376.2 6 6.3 cells per embryo)
compared with that of the control embryo (Figure S6A, 263.4
6 4.4 cells per embryo, n ¼ 5). Interestingly, exocrine cell
number in the exdpf morphants did not change much from 3
dpf to 5 dpf (from 21.6 6 3.4 to 22.8 6 3.8), indicating that
the proliferation rate of the exocrine cells is affected in
morphants.
Knocking Down exdpf Causes Cell Cycle Arrest but Not
Apoptosis of the Exocrine Cells
Knocking down exdpf gene by antisense morpholino leads
to loss or minimal formation of the exocrine pancreas. The
strong reduction of the exocrine pancreas could be a result of
increased cell death or decreased cell proliferation rate or a
combination of both. To address these possibilities, we
performed BrdU incorporation experiments to assess cell
proliferation. We chose the transgenic line MP760GFP to
assess exocrine pancreatic progenitor cell proliferation since
GFP expression is observed in the pancreatic area at 33 hpf, 1
h before exocrine cell differentiation (Song J, unpublished
data). At this stage, about 80% of exocrine pancreatic
progenitors were proliferating in the control embryos
injected with control morpholino (Figure 5A [top] and 5C,
Table 2). Injection of exdpf mRNA increased GFP positive cell
number by about 20% and 88% of the cells were proliferating
(Figure 5A [center] and 5C, Table 2). In contrast, knocking
down exdpf by morpholino caused a severe reduction of the
exocrine progenitor cell number by 70% (Figure 5C, Table 2)
and only 31% of the cells were proliferating (Figure 5A
[bottom] and 5C, Table 2). These results indicate that exdpf is
required for exocrine progenitor speciﬁcation and prolifer-
ation.
For differentiated exocrine cells, elastase A:GFP transgenic
ﬁsh was used to facilitate the identiﬁcation of exocrine cells.
We chose 3 dpf embryos to compare cell proliferating ability
because exocrine cells are still undergoing massive prolifer-
ation at this stage. At 3 dpf, in the control embryos, the BrdU
incorporation rate was about 85% (Figure 5B [top] and 5C,
Table 2). Injection of exdpf mRNA increased the BrdU
incorporation rate to about 98% (Figure 5B [center] and
5C, Table 2). This result suggests that exdpf is sufﬁcient to
promote exocrine cell proliferation. In contrast, knocking
down exdpf by morpholino signiﬁcantly reduced the BrdU
incorporation rate to about 17% (Figure 5B [bottom] and 5C,
Table 2), indicating that exdpf is also necessary for prolifer-
ation of differentiated exocrine cells.
To assess whether cell death could contribute to the severe
reduction of exocrine cells in the exdpf morphants, we
performed TUNEL assay on 5 dpf embryos because exocrine
cell number seems unchanged much from 3 dpf to 5 dpf. In
the control embryos, a small fraction of exocrine cells were
undergoing apoptosis (Figure S6C [enlargement] and S6J,
6.65% 6 2.66%, n ¼ 5). Overexpression of exdpf by injecting
synthetic mRNA increased exocrine cell number by ;40%.
Only basal level of cell death was detected in these embryos
(Figure S6F and S6J, 6.03% 6 2.43%, n ¼ 5). Similarly,
knocking down exdpf did not signiﬁcantly increase the ratio of
cells undergoing apoptosis (Figure S6I enlargement and S6J,
7.38% 6 3.24%, n ¼ 5). This result indicates that reduced
exdpf function did not cause massive cell death of the exocrine
pancreas.
exdpf Regulates Expression of Cell Cycle Genes
To address the molecular mechanisms causing cell cycle
arrest in the exdpf morphants, semi quantitative RT-PCR was
performed to examine the expression levels of cell cycle
inhibitors cyclin G1, p21
Cip, and p27
Kip, as well as G1 to S phase
regulator cyclin D1, at different developmental stages, includ-
ing 33 hpf (just before exocrine cell differentiation), 2 dpf
(exocrine cells surround the endocrine islet), 3 dpf (exocrine
cells expand posteriorly), and 5 dpf (exocrine cells form nice
pancreatic shape with head, trunk and tail). At 33 hpf, no
discernible difference of either p21
Cip or p27
Kip or cyclin G1
expression was detected in control, exdpf morphants, and exdpf
mRNA injected embryos (Figure 5D). From 2 dpf to 5 dpf, a
dramatic increase of p21
Cip expression (Figure 5D) was
observed in the exdpf morphants, whereas the expression
level remained comparable in the control and exdpf mRNA
injected embryos. Similarly, a signiﬁcant increase of p27
Kip
expression was also observed in the exdpf morphants, although
(C) Quantitative graphs for BrdU incorporation rate in 33 hpf or 3 dpf embryos. The average number of GFP positive cells with BrdU incorporation was
obtained by counting BrdU-labeled GFP positive cells from five embryos. Y axis: Mean 6 SD.
(D) Semiquantitative RT-PCR examination of expression of cyclin D1 and cell cycle inhibitors p21, p27 and cyclin G1 in control (control), exdpf morphants
(MO), and exdpf mRNA injected embryos (RNA) at 33 hpf, 2 dpf, 3 dpf, and 5 dpf. In each group, 30 embryos were used to extract total RNA for RT-PCR.
doi:10.1371/journal.pbio.0060293.g005
Table 2. Quantitative Data of BrdU Assay
Group 33 hpf 3 dpf
BrdU Positive Total Cell Number Percentage of BrdU Cells BrdU Positive Total Cell Number Percentage of BrdU Cells
Control 26 6 3.05 32 6 3.28 79.61% 169.6 6 8.2 197.8 6 8.2 84.93%
exdpf mRNA 34 6 3.28 38.67 6 5.04 87.92% 249.4 6 3.53 253 6 4.2 98.58%
exdpf MO 3 6 0.58 9.67 6 0.88 31.02% 3.6 6 3.43 21.6 6 3.4 16.67%
Average cell number 6 SD.
doi:10.1371/journal.pbio.0060293.t002
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Cip expression (Figure 5D, second row). In
addition, the expression of cyclin G1 also slowly increased in
the exdpf morphants from 2 dpf to 5 dpf. Taken together, our
results suggest that knocking down exdpf leads to cell cycle
arrests through up-regulation of p21
Cip, p27
Kip, and cyclin G1.
We have shown in our previous result that overexpression
of exdpf increased exocrine cell number due to overprolifera-
tion of these cells (Figure 5B, [center]). We then conﬁrmed
this result by checking the expression level of cyclin D1
through semiquantitative RT-PCR. At 33 hpf (just before
exocrine cell differentiation), cyclin D1 expression was slightly
increased in the exdpf mRNA injected embryos (Figure 5D).
From 2 dpf to 5 dpf, the increase of cyclin D1 expression in the
exdpf mRNA injected embryos became stronger. Interestingly,
we also detected elevated expression of cyclin D1 in the exdpf
morphants from 2 dpf to 5 dpf. We postulate that this type of
increase may be caused by exdpf independent mechanisms
that control organ size. Due to the strong increase of cell
cycle inhibitors in exdpf morphants, an increased level of cyclin
D1 is not enough to drive the cell into the proliferating phase.
The semi-quantitative RT-PCR results are further conﬁrmed
by real-time PCR (Table 3). Similar up-regulation of cell cycle
inhibitors including p21, p27, and cyclin G1 were detected in
the exdpf morphants (Table 3).
To examine where the increase of p21 expression comes
from, we performed in situ hybridization using a p21 probe.
At 33 hpf, p21 expression was detected in the developing
brain (Figure S7A and enlargement). No p21 expression was
observed in the developing pancreatic area. A similar p21
expression pattern was observed in expdf mRNA injected
embryos (Figure S7B and enlargement). Conversely, notice-
able p21 expression could be seen in the developing
pancreatic area in exdpf morphants (Figure S7C and enlarge-
ment). Thus, cell proliferation defects observed in the
developing exocrine pancreas caused by knocking down exdpf
are likely mediated by increased level of p21 expression in the
cells.
The exdpf Gene Acts Genetically Downstream of RA in
Regulating Exocrine Pancreas Development
We have shown that exdpf is essential for the exocrine
pancreas differentiation and expansion; overexpression of
exdpf gene leads to increased exocrine size. This effect is
similar to that of RA treatment (Figure 6). Embryos treated
with RA exhibited expanded endocrine pancreas [25].
Exogenous RA treatment also caused ectopic formation of
exocrine at positions anterior to the presumptive pancreatic
area (Figure 6B). But the exocrine pancreas failed to expand
toward the posterior at 5 dpf (unpublished data; only a small
number of embryos survived) as it did in untreated control
embryos. Interestingly, RA treatment of exdpf morphants
failed to induce exocrine formation (Figure 6D). This result
indicates that exocrine pancreas formation in RA-treated
embryos requires exdpf function.
In reciprocal experiments, treatment with 10
 6 M dieth-
ylaminobenzaldehyde (DEAB) to block the RA pathway often
resulted in no exocrine pancreas formation at 3dpf (Figure
6F, 85%, n¼181 embryos). Only about 15% (n¼181) of DEAB
treated embryos exhibited weak expression of an exocrine
marker at 3 dpf. This result suggests that RA is required for
early exocrine formation during normal pancreas develop-
ment. To test whether overexpression of exdpf can rescue
exocrine pancreas formation in the DEAB treated embryos,
we injected synthetic exdpf mRNA into embryos at the 1-cell
stage followed by treatment with 10
 6 M of DEAB from 9 hpf
up to the time of analysis. At 3 dpf, exdpf mRNA injection
increased the percentage of embryos exhibiting expression of
the exocrine marker cpa to 35% (Figure 6G and 6I, n ¼ 166).
This result suggests that exdpf acts downstream of the RA
pathway during normal pancreas development.
RA treatment often resulted in bilateral ectopic exocrine
formation at the anterior area (Figure 6N, 83%, n ¼ 191
embryos). To test whether exogenous RA treatment induces
exdpf expression, in situ hybridization using an exdpf probe
was performed. Interestingly, similar bilateral ectopic ex-
pression of exdpf was observed in RA treated embryos (Figure
6K). On the other hand, blocking RA synthesis by DEAB
completely abolished exdpf expression in the pancreatic area
(Figure 6L), whereas the epiphysis expression appeared
normal (Figure 6L, arrowhead). These data suggest RA
signaling inﬂuences exdpf expression in the developing
pancreas.
Taken together, these results place exdpf genetically down-
stream of RA in exocrine pancreas development.
Overexpression of exdpf Inhibits Endocrine b Cell
Development
The expression of the exdpf gene is excluded from the
endocrine islet during pancreatic development (Figure 1I).
To evaluate the effect of exdpf overexpression on endocrine
cell differentiation, we performed in situ hybridization
against preproinsulin in 3 dpf embryos (Figure 7). In the exdpf
mRNA injected embryos, preproinsulin expression was dra-
matically reduced (Figure 7B). Preproinsulin:GFP transgenic
ﬁsh were injected with exdpf mRNA to quantify the GFP-
positive cells. In the control embryos, the average number of
Table 3. Real-Time PCR Analysis Of Cell Cycle Control Genes
Gene 33 hpf 2 dpf 3 dpf 5 dpf
exdpf MO exdpf RNA exdpf MO exdpf RNA exdpf MO exdpf RNA exdpf MO exdpf RNA
p21 13.06 (0.0047) 1.45 (0.04) 23.65 (,0.001) 1.19 (0.028) 35.03 (0.001) 1.64 (0.03) 4.73 (,0.001) 1.06 (0.0117)
p27 0.74 (0.019) 1.23 (0.045) 0.51 (0.001) 0.95 (0.039) 2.69 (,0.001) 0.81 (0.001) 28.68 (,0.001) 1.22 (,0.001)
cyclin G1 1.14 (0.01) 1.24 (0.042) 3.39 (0.042) 1.10 (0.06) 14.84 (,0.001) 1.45 (0.08) 15.29 (0.04) 3.71 (0.045)
Cyclin D1 1.01 (,0.001) 1.97 (,0.001) 30.79 (,0.001) 38.79 (,0.001) 4.63 (,0.001) 9.84 (,0.001) 8.25 (0.006) 7.68 (0.049)
Ratio (p-value).
doi:10.1371/journal.pbio.0060293.t003
PLoS Biology | www.plosbiology.org November 2008 | Volume 6 | Issue 11 | e293 2458
Exdpf Controls Exocrine Pancreas FormationGFP positive cells was 45.15 6 7.04 (Figure 7F, mean 6 SD, n
¼ 20). As expected, overexpression of exdpf resulted in a
signiﬁcant reduction of GFP positive cell number by about
40%; the average number of GFP-expressing cell was 27.55 6
6.02 (Figure 7F, n¼20). The stage of 3 dpf is relatively late for
b cell development. To examine whether the reduction of b
cell number at 3 dpf is due to defects in cell proliferation or
speciﬁcation, we quantiﬁed preproinsulin:GFP positive cells at
24 hpf (see Figure S8 for panel of embryos used for
quantiﬁcation) when the majority of b cells come from newly
speciﬁed cells. Overexpression of exdpf reduced b cell number
by about 43% (Figure 7E, from 21.4 6 4.16 to 9.2 6 4.04 cells
per embryo). However, no signiﬁcant change in b cell number
was observed in the exdpf morphants (Figure 7E, 19.5 6 3.39
cells per embryo). These data indicate that overexpression of
exdpf inhibits b cell speciﬁcation and suggests a possible
transformation of cell fate in the endocrine pancreatic
precursors.
Exogenous RA treatment of WT embryos dramatically
increased preproinsulin-expressing cell number (Figure 7C and
7F, 212.15 6 14.88 cells per embryo, n ¼ 20) compared with
that in the DMSO treated control embryos (Figure 7A and 7F,
45.15 6 7.04, n¼20). Interestingly, overexpression of exdpf in
the RA treated embryos inhibited the anterior expansion of
the endocrine pancreas (Figure 7D and 7F, 105.2 6 10.88 cells
per embryo, n ¼ 20). This result suggests that overexpression
Figure 6. The exdpf Gene Acts Genetically Downstream of RA during Exocrine Pancreas Development
(A–G) In situ hybridization on 3 dpf embryos using a carboxypeptidase A (cpa) probe. (A) A WT control embryo. Note posterior expansion of exocrine
pancreas. (B) An example of WT embryo treated with 10
 6 M RA. Note exocrine pancreas is restricted to the anterior part in the endogenous position. (C)
An example of WT embryo injected with 2 ng of exdpf morpholino. Note exocrine pancreas is restricted to the head area in a similar fashion to (B). (D)
An example of WT embryo injected with 2 ng of exdpf morpholino followed by treatment of 10
 6 M RA. Note no cpa expression was detected. (E) A WT
embryo injected with 100 pg of exdpf mRNA. Note the increase of exocrine pancreas. (F) A WT embryo treated with 10
 6 M of DEAB. No cpa expression
was detected. (G) An example of WT embryo injected with 100 pg of exdpf mRNA followed by treatment with 10
 6 M of DEAB. Note cpa expression was
detected but not fully expanded posteriorly. All embryos were mounted anterior to the left, dorsal-lateral view. Scale bar: 50 lm.
(H) A quantitative graph showing the percentage of embryos with cpa expression corresponding to (A–D). Y-axis, percentage of embryos with cpa
expression. Mean 6 SD.
(I) A quantitative graph showing the percentage of embryos with cpa expression corresponding to (E–G) and control (A). Y-axis, percentage of embryos
with cpa expression. Mean 6 SD. In (H, I), percentage numbers are obtained from three independent experiments (n¼3). P value is from two-tail t-test
for two samples assuming unequal variance (experimental group versus control).
(J–O) In situ hybridization results using an exdpf or trypsin probe. (J and M) WT embryos treated with DMSO as controls. (K and N) WT embryos treated
with 10
 6 M of RA. Note no exdpf or trypsin expression posterior to the white arrows. (L and O) WT embryos treated with 10
 6 M of DEAB.
doi:10.1371/journal.pbio.0060293.g006
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Exdpf Controls Exocrine Pancreas Formationof exdpf in the anterior ectopic pancreas induced by RA
treatment balanced RA signaling and turned more cells into
the exocrine fate.
Discussion
Our results provide strong evidence that a novel gene exdpf
is speciﬁcally employed by the zebraﬁsh exocrine progenitors
to promote cell differentiation and proliferation. Moreover,
epistasis experiments support that exdpf functions down-
stream of ptf1a in exocrine cell speciﬁcation. RA also interacts
genetically with Exdpf during exocrine formation.
How does Exdpf regulate exocrine cell speciﬁcation? First,
exdpf starts to express in exocrine progenitors at 33 hpf, just
before exocrine cell differentiation. Second, exdpf is required
for exocrine cell differentiation. Knocking down exdpf by
antisense morpholino resulted in the absence of exocrine
markers in a majority of injected embryos. The remaining
smaller fraction of exdpf morphants exhibited signiﬁcantly
reduced expression of exocrine markers. Third, exdpf is both
necessary and sufﬁcient for exocrine cell proliferation. We
observed exdpf overexpression increased the proliferation of
exocrine cells (98% versus 85% in the control embryos),
whereas knocking down exdpf severely impaired proliferating
Figure 7. Overexpression of exdpf Represses Endocrine Cell Differentiation in Both WT and RA-Treated embryos
(A–D) In situ hybridization on 3 dpf embryos using a preproinsulin probe. Enlargement: higher magnification of pancreatic area. (A) A WT embryo
treated with DMSO as control. (B) A WT embryo injected with 100 pg of exdpf mRNA. (C) A WT embryo treated with 10
 6 M of RA. Note anterior
expansion of endocrine cells at the endogenous position and anterior ectopic endocrine cells (arrows). (D) A WT embryo injected with 100 pg of exdpf
mRNA followed by RA treatment. Note weak anterior ectopic endocrine cells (arrowheads). Scale bar: 50 lm.
(E) A quantitative graph showing average GFP-positive cells per preproinsulin:GFP embryo at 24 hpf. Y axis, Mean 6 SD.
(F) A quantitative graph showing average GFP-positive cells per preproinsulin:GFP embryo at 3 dpf. Y axis, Mean 6 SD.
(G) A model for the effect of exdpf on endocrine cell differentiation. Normally, exdpf is only expressed in the exocrine cell precursors after endocrine cell
differentiation. Injection of exdpf mRNA caused ectopic expression of exdpf in the committed pancreatic progenitors before endocrine cell
differentiation. Therefore, more progenitors are transformed into exocrine cell fate and fewer progenitors develop into endocrine cells.
doi:10.1371/journal.pbio.0060293.g007
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Exdpf Controls Exocrine Pancreas Formationability due to the increased level of cell cycle inhibitors p21
Cip,
p27
Kip, and cyclin G1. Although exdpf is necessary for exocrine
cell differentiation, it is not sufﬁcient to induce ectopic
formation of the exocrine pancreas. A possible explanation is
that exdpf only functions in the committed exocrine progen-
itors. Our result shows that Exdpf promotes exocrine cell
proliferation by regulating cyclin D expression.
Exdpf acts genetically downstream of ptf1a in exocrine
speciﬁcation. It is likely that ptf1a controls the expression of
exdpf in exocrine progenitors. The expression pattern of exdpf
in exocrine pancreas is similar to that of ptf1a [36]. ptf1a is
expressed in the exocrine progenitors at 32 hpf. Similarly,
ptf1a-expressing cells also surround b cells as a result of gut
rotation [36]. In addition, three Ptf1a binding sites have been
identiﬁed in the promoter region of the exdpf gene (Figure
4C). Using luciferase assay, we were able to show that these
Ptf1a binding sites are functional in culture cells. Thus, exdpf
is a direct target gene of Ptf1a. Other transcription factors
such as Pdx1 might also control exocrine progenitor speciﬁc
expression of exdpf. During embryogenesis, ptf1a is expressed
in the ventral aspect of pdx1-positive domain from 32 hpf to
36 hpf [36]. Moreover, two Pdx1 binding sites have also been
identiﬁed within exdpf promoter region (data not shown).
Knocking down of ptf1a leads to the agenesis of the exocrine
pancreas, which is consistent with previous results [36,37].
Injection of exdpf mRNA into the ptf1a morphants successfully
restored the expression of the exocrine marker. This is likely
due to the expansion and differentiation of residual
progenitor cells promoted by exdpf mRNA in the Ptf1a
morphants. In our rescue experiments, the injected concen-
tration of ptf1a morpholino only created a hypomorph
situation and should still contain a residual pool of
progenitors. Co-injection of exdpf mRNA promotes prolifer-
ation and differentiation of these cells, resulting rescue of the
defect. It is also likely that Ptf1a activity recovers following
cessation of the morpholino effect, and that this allows for
full exocrine differentiation to occur in progenitor cells that
have been rescued by exogenous exdpf. Nonetheless, our
results provide evidence that Exdpf acts downstream of ptf1a
in exocrine formation. In addition, overexpression of exdpf by
mRNA injection inhibited endocrine cell fates (Figure 7B, 7E,
and 7F). This endocrine repression result is in agreement with
a recent report by Dong et al. Using partial loss of function
analysis for ptf1a, Dong et al. found that high levels of ptf1a
promote exocrine fate whereas low levels promote endocrine
fate [44]. It is likely that ptf1a exerts its function through exdpf
in this aspect.
The exdpf gene encodes a putative signaling molecule
containing two SH2 and two SH3 domains as well as other
conserved domains (Figure S4), suggesting that Exdpf may
function in response to signals from adjacent mesoderm
tissues. Multiple intercellular signals including transforming
growth factor beta, Hedgehog, and Notch are critical for the
proper speciﬁcation of endocrine and exocrine cell fates
during pancreas development. It is not clear which signal or
signals exdpf responds to in order to make the exocrine cell
fate decision. Our results support the idea that exdpf
promotes exocrine cell proliferation. As a putative signaling
molecule, exdpf might be involved in transducing signals from
growth factors that are required for exocrine cell prolifer-
ation. However, the identities of such growth factors remain
elusive.
Genetic evidence places exdpf downstream of RA. Exoge-
nous treatment with RA caused anterior expansion of
endocrine cells as well as ectopic anterior exocrine cells,
which is consistent with previous results [25]. Contradictory
results from RA treatment have been reported using different
organisms regarding exocrine development. In mouse embry-
onic culture, RA treatment suppresses exocrine differentia-
tion and branching morphogenesis [30,45]. Others reported
that atRA treatment leads to endocrine and duct differ-
entiation from the pancreatic bud, but inhibits exocrine
differentiation [45]. In Xenopus, exogenous RA treatment
causes endocrine expansion in the dorsal bud at the expense
of exocrine tissue but stimulates exocrine differentiation in
the ventral bud [26]. These contradictory results might derive
from different organisms and different concentrations of
either atRA or 9cis RA. In our experiment, we ﬁnd that
excessive atRA caused ectopic anterior exocrine formation.
Exogenous treatment with RA induced ectopic pancreatic
cells including endocrine and exocrine cells. Anterior ectopic
formation of the exocrine pancreas by RA treatment requires
exdpf function since exdpf morpholino injection blocks ectopic
exocrine formation and RA also induces anterior ectopic
expression of exdpf. Overexpression of exdpf in wild-type
embryos signiﬁcantly suppresses endocrine cell differentia-
tion, suggesting exdpf transforms the cell fate of pancreatic
progenitors (Figure 7G). The balance of RA and overex-
pressed exdpf in the progenitors results in reduced endocrine
cells compared with RA treated wild-type embryos.
Pancreatic cancer is one of the leading causes of cancer
deaths because it is often highly aggressive and resistant to
treatments available at the time of diagnosis [46]. Genetic
studies have identiﬁed structural mutations in pancreatic
cancers; the alterations include the activation of K-Ras proto-
oncogene as well as inactivation of tumor suppressor genes
such as TP53 or INK4a locus [47–49]. By carefully searching
the NCBI database, we found that the human exdpf ortholog is
expressed in relatively high levels in multiple tissues includ-
ing the pancreas, colon, and mammary glands. Interestingly,
the EST expression proﬁle also indicates that higher level of
exdpf ortholog has been detected in several cancers including
pancreatic cancer, breast cancer and kidney cancer (Figure
S9). In addition to structural mutations, many growth factor
receptors and their ligands are overexpressed in pancreatic
cancers. Since exdpf can promote acinar cell proliferation, it is
worth studying the role of this gene in pancreatic cancer.
Zebraﬁsh has proven to be a useful model system to study
pancreatic cancers. In 2004, Yang et al. reported that human
MYCN caused pancreatic neuroendocrine tumors in trans-
genic zebraﬁsh that expressed MYCN in b cells, muscle cells
and neurons [50]. Recently, transgenic ﬁsh that express
oncogenic KRAS
G12V under the ptf1a promoter was gener-
ated. In these ﬁsh, KRAS
G12V blocked the differentiation of
pancreatic progenitor cells and this undifferentiated progen-
itor pool lead to invasive pancreatic cancer [51]. These
examples demonstrate that the zebraﬁsh model is useful in
advancing our understanding of pancreatic cancers.
Together, our results reveal a speciﬁc requirement for
Exdpf in exocrine pancreas formation in zebraﬁsh. The gene
exdpf is expressed exclusively in the exocrine progenitors and
differentiated exocrine cells. We demonstrate that exdpf is
necessary for exocrine cell differentiation. Furthermore, exdpf
is both sufﬁcient and necessary for the proliferation of
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the function of exdpf in pancreatic cancers could shed light on
the pathogenesis of this malignancy.
Materials and Methods
Zebraﬁsh husbandry. Zebraﬁsh were raised and kept under
standard laboratory conditions at about 28 8C. Embryos were staged
according to Kimmel et al. [52]. The elastase A:GFP ﬁsh was a gift from
Gong’s laboratory in Singapore [43]. The wild-type line used was AB.
In situ hybridization. In situ hybridization was performed
essentially as previously described [53]. For double in situ hybrid-
ization, Fast Red (Roche) and NBT/BCIP (50 mg/ml; Promega) were
used as alkaline phosphatase substrates. The following probes were
used: preproinsulin [54], trypsin, cpa, ptf1a, p21, and exdpf.
Chemical treatment. For RA treatment, wild-type zebraﬁsh
embryos were incubated with retinoic acid as described [25]. For
DEAB treatment, embryos were incubated with 10
 6 M DEAB diluted
from 10
 2 M stock solution in DMSO as described [55].
RNA synthesis and injection. mRNAs of exdpf and ptf1a were
synthesized using T7 or SP6 mMessage mMachine kit (Ambion).
mRNA injection was performed as described at the one-cell stage [56].
Sterile water was used for the control experiments. 100 pg of exdpf or
ptf1a mRNA was used for all experiments.
Injection of antisense morpholino oligonucleotides. Antisense
morpholino oligos (MOs) designed against exdpf: MO1: 59-GCTGG-
ATGGAATTGCTGCCATTTTC-39. MO2: 59-TCGACCGTGTGGAA-
GATGGAAAGAT-39 were obtained from Gene Tools. Ptf1a-MOa,
59-AGTGTCCATTTTTTGTGCTGTGTTG-39 was obtained from
Open Biosystems and injected into one- to two-cell stage embryos
(for original reference, see [36]). A morpholino standard control oligo
(59-CCTCTTACCTCAGTTACAATTTATA-39) used as control was
obtained from Gene Tools. All morpholinos were prepared and
resuspended in 13 Danieau’s buffer at 1 ng/nl for injection.
BrdU staining. Embryos were placed in 10 mM solution of BrdU
(Sigma) in ﬁsh water at 24 hpf and kept in dark at 28 8C for 48 h. Then
embryos were ﬁxed in 4% PFA for 2 h at room temperature. After
washing (535 min in PBST), embryos were incubated in 1 N HCl for
1 h. Then embryos were washed again for 5 3 5 min in PBST and
blocked using 5% goat serum for 1 h at room temperature and
incubated over night at 4 8C in 1:100 mouse anti-BrdU monoclonal
antibody (Chemicon) and 1:500 rabbit anti-GFP polyclonal antibody
(Abcam). After washing (535 min in PBST), embryos were incubated
overnight at 4 8C in 1:200 A488 conjugated goat anti-rabbit antibody
(Molecular Probe). Embryos were then washed and incubated in 1:200
TRITC conjugated rabbit anti-mouse antibody (Sigma) over night at 4
8C. The stained embryos were incubated with DAPI for 30 min and
visualized via a Zeiss LSM 510 Laser Confocal Microscope.
TUNEL assay. The terminal deoxynucleotidyl transferase–medi-
ated dUTP-ﬂuoroscein nick-end labeling (TUNEL) assay was per-
formed essentially as described previously [57]. Embryos were ﬁxed
overnight in 4% PFA in PBS at 4 8C and permeabilized using
methanol. Then embryos were rehydrated and washed 5 3 5 min in
PBST at room temperature. TUNEL labeling was performed by 1 h
incubation at 37 8C in a cell death detection reagent (in situ cell death
Detection Kit-TMR Red, Roche Diagnostics). As negative controls,
embryos were incubated in the TUNEL label only. For positive
controls, embryos were treated with DNaseI for 1 h at 37 8C before
TUNEL labeling. After the reaction, embryos were washed 4315 min
in PBST at room temperature and stored in PBST at 4 8C in a covered
canister. Fluorescence was detected using a Zeiss LSM 510 Laser
Scanning Confocal Microscope.
Imaging and quantiﬁcation. Images were captured using a digital
camera (Axiocam) attached to a compound microscope (Zeiss:
Axioplan 2 or Imager A1) and Improvision (an Openlab program)
or Axiovision. Confocal images were captured using a Zeiss LSM 510
Laser Scanning Confocal Microscope. To quantify elastase A:GFP-
positive cell numbers, yolk was removed from the embryo and the
rest of the embryo was ﬂattened by cover slide. GFP-positive cells
were used to outline exocrine and DAPI staining inside the exocrine
area was counted under a compound microscope. Calculations were
performed using Microsoft Excel. We report mean and standard
deviation of exocrine cell numbers. The probability associated with
the Student’s t-test (with two-tailed distribution) and two samples of
unequal variance were also included.
RT-PCR and real-time PCR. RT-PCR was performed for transcript
analysis of p21
Cip, p27
Kip, cyclin D1, cyclin G1, and EF1a. Total RNA was
extracted from 30 embryos of each group at various developmental
stages using Qiagen Rneasy Mini kit (Qiagen, Valencia, CA). The total
RNA pellet was resuspended in 30 ll of RNase free water and stored
at 80 8C. For reverse transcription, 10 ll of RNA was mixed with 1 ll
of random primer and incubated for 5 min at 68 8C and placed on ice.
For each reaction, a mix of 4 llo f5 3RT buffer (50 mM Tris-HCl, 75
mM KCl, 3 mM MgCl2; Invitrogen, Carlsbad, CA), 2 ll of dNTPmix (10
mM), 2 ll of DTT (100 mM), and 1 ll of M-MLV reverse transcriptase
(200 U; Invitrogen, Carlsbad, CA, Canada) was added and samples
were incubated for 1 h at 42 8C followed by 10 min at 68 8C. To test
for genomic DNA contamination, equivalent RNA samples were
treated in the same manner, except that RNase-free water was added
to the reaction instead of the reverse transcriptase. RT-PCR primer
sequences and reaction conditions are presented in Table S1. Real-
time PCR was performed using Bio-Rad CYBR Green Supermix on
iCycler. For each time point, triplicate was used to determine the
ratio of experimental group versus control. Standard curve method
was used. p-Values were obtained using the Student’s t-test (with two-
tailed distribution) and two samples of unequal variance.
Luciferase assay. Exdpf promoter sequences were generated by the
polymerase chain reaction (PCR) with Long Taq PCR Mastermix
(TIANGEN) from genomic DNA of AB zebraﬁsh. The fragments of
the exdpf promoter obtained were inserted into the pGL3-Basic vector
(Promega).
Zebraﬁsh Ptf1a, human E47 and RBP-J expression constructs were
kindly provided by Steven D. Leach [58], Michael Chin [59], and S.
Diane Hayward [60], respectively. Human embryonic kidney 293 cells
were plated at 70% conﬂuence in 24-well plates and transfected with
0.8 lg of DNA per well using Lipofectamine 2000 (Invitrogen)
following the manufacturer’s protocol. A Renilla luciferase control
plasmid (Promega Dual-Luciferase Reporter Assay System) was
included in all transfections to allow normalization for transfection
efﬁciency. Total DNA content per well was made consistent by
supplementing with pCDNA3.1(þ) vector when necessary. Ptf1-
activated luciferase activity was deﬁned as the ratio of ﬁreﬂy to
Renilla luciferase luminescence and is further normalized against
luciferase activity from cells transfected with the pGL3-Basic
construct. All values are the means of at least three transfections 6
standard error of the mean.
Supporting Information
Figure S1. Vertebrate Orthologs of Exdpf are Highly Conserved
(A) Peptide sequences of zebraﬁsh Exdpf and Exdpfh (Endpf) aligned
with mouse and human c20orf149 proteins using the ClustalW WWW
Service at the European Bioinformatics Institute (http://www.ebi.ac.
uk/clustalw; (Thompson et al., 1994). ‘*’ indicate positions that have a
single, fully conserved residue. ‘:’ and ‘.’ indicate positions that have
strong (:) and weak (.) similarities. Dashes indicate gaps.
(B) Comparison of the genomic location of exdpf and endpf genes in
zebraﬁsh and human. Lines connecting locations indicate homolo-
gous genes.
Found at doi:10.1371/journal.pbio.0060293.sg001 (2.8 MB TIF).
Figure S2. RT-PCR Result of exdpf During Embryogenesis
Note exdpf can be detected at one-cell stage, indicating that the
transcripts are maternally deposited into the eggs. Zygotic expression
of exdpf starts at around shield stage and increases during subsequent
embryogenesis. A strong level of exdpf expression can be detected at 2
dpf and lasts until 5 dpf, the longest time point of this analysis.
Found at doi:10.1371/journal.pbio.0060293.sg002 (165 KB TIF).
Figure S3. Exdpf Antisense Morpholino Oligonucleotide MO2
Inhibits Exocrine Pancreas Formation
(A and B) In situ hybridization using a carboxypeptidase A (cpa) probe.
(A) A wild-type (WT) embryo injected with 2 ng of standard
morpholino oligonucleotide control. White arrow head: cpa expres-
sion in pancreas. (B) An embryo injected with 2 ng of exdpf MO2. Note
severely reduced expression of cpa (white arrow).
(C) An embryo injected with 4 ng of exdpf MO2.
(D) An embryo injected with 6 ng of exdpf MO2.
Found at doi:10.1371/journal.pbio.0060293.sg003 (1.2 MB TIF).
Figure S4. Predicted Domains of Exdpf Protein
PROSITE (http://www.expasy.org/prosite) was used to predicate func-
tional domains in Exdpf protein. The predicated domains and
phosphorylation site as well as ATP binding site are listed.
Found at doi:10.1371/journal.pbio.0060293.sg004 (949 KB TIF).
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Exdpf Controls Exocrine Pancreas FormationFigure S5. Exdpf is Speciﬁcally Required for Exocrine Pancreas
Formation but not Gut or Liver
(A–C) Expression of GFP MP760GFP transgenic ﬁsh. (A) A control
embryo injected with standard control morpholino. Note strong GFP
expression in the pancreatic area at 24 hpf (arrow) and 2 dpf
(arrowhead). (B) An example of embryo injected with exdpf mRNA
(100 pg). Note strong GFP expression in the pancreatic area at 24 hpf
(arrow) and 2 dpf (arrowhead). GFP expression in the developing gut
is comparable to that in control embryo. (C) An example of embryo
injected with exdpf morpholino (2ng of MO1
exdpf). Note no strong GFP
expression in the presumed pancreatic area at 24 hpf (arrow). A weak
GFP positive pancreatic bud can be observed at 2 dpf (arrowhead).
GFP expression in the gut is still comparable to that in the control
and exdpf RNA injected embryos.
(D–G) In situ hybridization using a ceruloplasmin probe with 3 dpf
embryos. (D) A control embryo injected with standard morpholino
control. (E–G) Examples of embryos injected with exdpf morpholino.
Note comparable expression of cerulaplasmin in all embryos.
Found at doi:10.1371/journal.pbio.0060293.sg005 (6.2 MB TIF).
Figure S6. Reduced exdpf Does not Affect Apoptosis in the
Developing Pancreas
(TUNEL assay result in 5 dpf embryos.
(A–C) A control embryo injected with standard morpholino control.
Enlargement: of boxed area in (C). Note a few cell debris representing
cells undergoing apoptosis (arrows in C enlargement).
(D–F) An embryo injected with 100 pg of exdpf mRNA. Enlargement:
of boxed area in (F). Note comparable number of cells undergoing
apoptosis (arrows).
(G–I) An embryo injected with exdpf morpholino. Enlargement: of
boxed area in (I). Note both exocrine cells (arrows) and non-exocrine
cells (arrowhead) undergoing apoptosis. Lateral view, anterior to the
left. Scale bar: 50 lm.
(J) A quantitative graph of TUNEL assay.
Found at doi:10.1371/journal.pbio.0060293.sg006 (2 MB TIF).
Figure S7. Reduced exdpf Speciﬁcally Increases p21 Expression in the
Pancreatic Area
In situ hybridization using a p21 probe.
(A) A control embryo injected with standard morpholino control.
Note p21 expression in the head area. No p21 expression is detected
in the pancreatic area.
(B) An embryo injected with exdpf mRNA (100 pg). Note p21
expression in the head area. No p21 expression is detected in the
pancreatic area.
(C) An embryo injected with exdpf morpholino. Note p21 expression
in the pancreatic area (arrow).
Found at doi:10.1371/journal.pbio.0060293.sg007 (3.5 MB TIF).
Figure S8. Examples of preproinsulin:GFP Embryos Used for Cell
Counting
Green: preproinsulin:GFP. Blue: DAPI staining. All embryos are at 24
hpf, de-yolked and ﬂat mounted.
Found at doi:10.1371/journal.pbio.0060293.sg008 (6 MB TIF).
Figure S9. ExpressionofHumanexdpfinNormalTissuesandinTumors
Human exdpf ortholog is expressed in different organs including
colon, kidney, liver, and pancreas. Relatively higher level of exdpf has
been detected in several tumors including colorectal caner, kidney
tumor, liver tumor, and pancreatic tumor.
Found at doi:10.1371/journal.pbio.0060293.sg009 (741 KB TIF).
Table S1. Primers Used for RT-PCR and Real-Time PCR
The sequences of forward and reverse primers and product length for
each gene tested are included.
Found at doi:10.1371/journal.pbio.0060293.st001 (27 KB DOC).
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